- Home
- PBT vs EYPT Comparison
PBT vs EYPT Comparison
Compare PBT & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- EYPT
- Stock Information
- Founded
- PBT 1980
- EYPT 1987
- Country
- PBT United States
- EYPT United States
- Employees
- PBT N/A
- EYPT N/A
- Industry
- PBT Oil & Gas Production
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- PBT Energy
- EYPT Industrials
- Exchange
- PBT Nasdaq
- EYPT Nasdaq
- Market Cap
- PBT 562.6M
- EYPT 579.4M
- IPO Year
- PBT N/A
- EYPT 2005
- Fundamental
- Price
- PBT $12.72
- EYPT $9.66
- Analyst Decision
- PBT
- EYPT Strong Buy
- Analyst Count
- PBT 0
- EYPT 8
- Target Price
- PBT N/A
- EYPT $24.75
- AVG Volume (30 Days)
- PBT 128.7K
- EYPT 772.8K
- Earning Date
- PBT 01-01-0001
- EYPT 08-06-2025
- Dividend Yield
- PBT 4.28%
- EYPT N/A
- EPS Growth
- PBT N/A
- EYPT N/A
- EPS
- PBT 0.48
- EYPT N/A
- Revenue
- PBT $24,140,674.00
- EYPT $56,042,000.00
- Revenue This Year
- PBT N/A
- EYPT N/A
- Revenue Next Year
- PBT N/A
- EYPT N/A
- P/E Ratio
- PBT $26.10
- EYPT N/A
- Revenue Growth
- PBT N/A
- EYPT 12.04
- 52 Week Low
- PBT $8.01
- EYPT $3.91
- 52 Week High
- PBT $14.26
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- PBT 79.49
- EYPT 61.95
- Support Level
- PBT $12.32
- EYPT $8.96
- Resistance Level
- PBT $12.60
- EYPT $10.77
- Average True Range (ATR)
- PBT 0.31
- EYPT 0.77
- MACD
- PBT 0.04
- EYPT -0.02
- Stochastic Oscillator
- PBT 81.53
- EYPT 60.78
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.